<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">39203960</PMID><DateRevised><Year>2024</Year><Month>09</Month><Day>01</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Print">2076-393X</ISSN><JournalIssue CitedMedium="Print"><Volume>12</Volume><Issue>8</Issue><PubDate><Year>2024</Year><Month>Jul</Month><Day>24</Day></PubDate></JournalIssue><Title>Vaccines</Title><ISOAbbreviation>Vaccines (Basel)</ISOAbbreviation></Journal><ArticleTitle>The Immunomodulatory Function of Assembled Composite Nanopolypeptide Containing Bursal-Derived BP7 (CNPB7) in Promoting the Mucosal Immune Response within Poultry Immunization.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">834</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/vaccines12080834</ELocationID><Abstract><AbstractText>Mucosal immunity is the main defense line against respiratory disease pathogens. Newcastle disease and avian infectious bronchitis are common respiratory diseases in poultry. However, the mucosal immune response is not sufficiently activated and thus fails to achieve the ideal immune protection. Therefore, it is important to develop a suitable mucosal immune adjuvant to enhance the immune response of live vaccines. Here, the bursal-derived peptide BP7, β-glucan, and hyaluronic acid were selected as the adjuvant to be assembled into the composite nanopolypeptide adjuvant (CNPB7) with ultrasonic dispersion technology. The results showed that after optimizing assembly conditions, the optimal average particle size of nanoparticle CNPB7 was 514.9 nm and PDI was 0.298. To evaluate the non-specific immune responses of nanoparticle CNPB7, the chickens were immunized only with nanoparticle CNPB7. It was confirmed that nanoparticle CNPB7 enhanced the expression of CD3, CD4, CD80, and CD86 factors in the spleen lymphocyte from the chicken immunized with nanoparticle CNPB7. To investigate the mucosal immune response of nanoparticle CNPB7, the chickens were orally immunized with Newcastle disease virus (NDV)-infectious bronchitis virus (IBV) dual vaccines and CNPB7. The results proved that the levels of immunoglobulin SIgA, IL-4, IFN-γ, and IL-13 in the mucus samples from the respiratory and digestive tract in chicken immunized with nanoparticle CNPB7 and vaccines were significantly increased, compared to that of vaccine control. Finally, it was observed that nanoparticle CNPB7 promoted specific increased antibody productions against NDV and IBV in the immunized chicken. These results proved that the assembled nanoparticle CNPB7 could enhance the vaccination efficacy in chicken, which provided the experimental basis for the development of new adjuvants, and offered technical support for preventing virus transmission of avian diseases.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Guo</LastName><ForeName>Xinyu</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Key Laboratory of Animal Microbiology of China's Ministry of Agriculture, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing 210095, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>MOE Joint International Research Laboratory of Animal Health and Food Safety, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing 210095, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Hu</LastName><ForeName>Jianing</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Key Laboratory of Animal Microbiology of China's Ministry of Agriculture, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing 210095, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>MOE Joint International Research Laboratory of Animal Health and Food Safety, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing 210095, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yin</LastName><ForeName>Guihu</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Key Laboratory of Animal Microbiology of China's Ministry of Agriculture, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing 210095, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>MOE Joint International Research Laboratory of Animal Health and Food Safety, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing 210095, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cai</LastName><ForeName>Yiqin</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Key Laboratory of Animal Microbiology of China's Ministry of Agriculture, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing 210095, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>MOE Joint International Research Laboratory of Animal Health and Food Safety, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing 210095, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gao</LastName><ForeName>Zichen</ForeName><Initials>Z</Initials><AffiliationInfo><Affiliation>Key Laboratory of Animal Microbiology of China's Ministry of Agriculture, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing 210095, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>MOE Joint International Research Laboratory of Animal Health and Food Safety, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing 210095, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Liu</LastName><ForeName>Ye</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Key Laboratory of Animal Microbiology of China's Ministry of Agriculture, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing 210095, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>MOE Joint International Research Laboratory of Animal Health and Food Safety, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing 210095, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhong</LastName><ForeName>Meng</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Key Laboratory of Animal Microbiology of China's Ministry of Agriculture, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing 210095, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>MOE Joint International Research Laboratory of Animal Health and Food Safety, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing 210095, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Ruiying</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Key Laboratory of Animal Microbiology of China's Ministry of Agriculture, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing 210095, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>MOE Joint International Research Laboratory of Animal Health and Food Safety, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing 210095, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Feng</LastName><ForeName>Xiuli</ForeName><Initials>X</Initials><Identifier Source="ORCID">0000-0001-9824-8386</Identifier><AffiliationInfo><Affiliation>Key Laboratory of Animal Microbiology of China's Ministry of Agriculture, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing 210095, China.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>MOE Joint International Research Laboratory of Animal Health and Food Safety, College of Veterinary Medicine, Nanjing Agricultural University, Nanjing 210095, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>(CX(22)3035)</GrantID><Agency>Jiangsu Province Agricultural Science and Technology Independent Innovation Fund Project</Agency><Country /></Grant><Grant><GrantID>grant number: 31872458</GrantID><Agency>National Natural Science Foundation</Agency><Country /></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2024</Year><Month>07</Month><Day>24</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Vaccines (Basel)</MedlineTA><NlmUniqueID>101629355</NlmUniqueID><ISSNLinking>2076-393X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">antibody production</Keyword><Keyword MajorTopicYN="N">composite nanoparticles CNPB7</Keyword><Keyword MajorTopicYN="N">mucosal immune response</Keyword><Keyword MajorTopicYN="N">non-specific immune response</Keyword><Keyword MajorTopicYN="N">polypeptide self-assembly</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2024</Year><Month>6</Month><Day>12</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2024</Year><Month>7</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2024</Year><Month>7</Month><Day>22</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2024</Year><Month>8</Month><Day>31</Day><Hour>9</Hour><Minute>47</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2024</Year><Month>8</Month><Day>31</Day><Hour>9</Hour><Minute>46</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2024</Year><Month>8</Month><Day>29</Day><Hour>1</Hour><Minute>26</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2024</Year><Month>7</Month><Day>24</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">39203960</ArticleId><ArticleId IdType="pmc">PMC11360326</ArticleId><ArticleId IdType="doi">10.3390/vaccines12080834</ArticleId><ArticleId IdType="pii">vaccines12080834</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Zhao T., Cai Y., Jiang Y., He X., Wei Y., Yu Y., Tian X. Vaccine Adjuvants: Mechanisms and Platforms. Signal Transduct. Target. Ther. 2023;8:283. doi: 10.1038/s41392-023-01557-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41392-023-01557-7</ArticleId><ArticleId IdType="pmc">PMC10356842</ArticleId><ArticleId IdType="pubmed">37468460</ArticleId></ArticleIdList></Reference><Reference><Citation>Verma S.K., Mahajan P., Singh N.K., Gupta A., Aggarwal R., Rappuoli R., Johri A.K. New-Age Vaccine Adjuvants, Their Development, and Future Perspective. Front. Immunol. 2023;14:1043109. doi: 10.3389/fimmu.2023.1043109.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1043109</ArticleId><ArticleId IdType="pmc">PMC9998920</ArticleId><ArticleId IdType="pubmed">36911719</ArticleId></ArticleIdList></Reference><Reference><Citation>Dimitrov K.M., Afonso C.L., Yu Q.Z., Miller P.J. Newcastle Disease Vaccines—A Solved Problem or a Continuous Challenge? Vet. Microbiol. 2017;206:126–136. doi: 10.1016/j.vetmic.2016.12.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vetmic.2016.12.019</ArticleId><ArticleId IdType="pmc">PMC7131810</ArticleId><ArticleId IdType="pubmed">28024856</ArticleId></ArticleIdList></Reference><Reference><Citation>Falchieri M., Coward V.J., Reid S.M., Lewis T., Banyard A.C. Infectious Bronchitis Virus: An Overview of the “Chicken Coronavirus”. J. Med. Microbiol. 2024;73:001828. doi: 10.1099/jmm.0.001828.</Citation><ArticleIdList><ArticleId IdType="doi">10.1099/jmm.0.001828</ArticleId><ArticleId IdType="pmc">PMC11184965</ArticleId><ArticleId IdType="pubmed">38771617</ArticleId></ArticleIdList></Reference><Reference><Citation>Dotiwala F., Upadhyay A.K. Next Generation Mucosal Vaccine Strategy for Respiratory Pathogens. Vaccines. 2023;11:1585. doi: 10.3390/vaccines11101585.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines11101585</ArticleId><ArticleId IdType="pmc">PMC10611113</ArticleId><ArticleId IdType="pubmed">37896988</ArticleId></ArticleIdList></Reference><Reference><Citation>Lavelle E.C., Ward R.W. Mucosal Vaccines—Fortifying the Frontiers. Nat. Rev. Immunol. 2022;22:236–250. doi: 10.1038/s41577-021-00583-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-021-00583-2</ArticleId><ArticleId IdType="pmc">PMC8312369</ArticleId><ArticleId IdType="pubmed">34312520</ArticleId></ArticleIdList></Reference><Reference><Citation>Ren H., Jia W., Xie Y., Yu M., Chen Y. Adjuvant Physiochemistry and Advanced Nanotechnology for Vaccine Development. Chem. Soc. Rev. 2023;52:5172–5254. doi: 10.1039/D2CS00848C.</Citation><ArticleIdList><ArticleId IdType="doi">10.1039/D2CS00848C</ArticleId><ArticleId IdType="pubmed">37462107</ArticleId></ArticleIdList></Reference><Reference><Citation>Feng X.L., Zheng Y., Zong M.M., Hao S.S., Zhou G.F., Cao R.B., Chen P.Y., Liu Q.T. The Immunomodulatory Functions and Molecular Mechanism of a New Bursal Heptapeptide (BP7) in Immune Responses and Immature B Cells. Vet. Res. 2019;50:64. doi: 10.1186/s13567-019-0682-7.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13567-019-0682-7</ArticleId><ArticleId IdType="pmc">PMC6749628</ArticleId><ArticleId IdType="pubmed">31533803</ArticleId></ArticleIdList></Reference><Reference><Citation>Dong X., Bie J., Liu X. Research Note: Isolation and Immunomodulatory Activity of Bursal Peptide, a Novel Peptide from Avian Immune System Developments. Poult. Sci. 2024;103:103–294. doi: 10.1016/j.psj.2023.103294.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.psj.2023.103294</ArticleId><ArticleId IdType="pmc">PMC10711509</ArticleId><ArticleId IdType="pubmed">38042040</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai J., Zhang Z., Li C., Hao S., Lu A., Huang X., Feng X. Bursal-Derived BP7 Induces the miRNA Molecular Basis of Chicken Macrophages and Promotes the Differentiation of B Cells. Vaccines. 2022;10:1960. doi: 10.3390/vaccines10111960.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines10111960</ArticleId><ArticleId IdType="pmc">PMC9698346</ArticleId><ArticleId IdType="pubmed">36423055</ArticleId></ArticleIdList></Reference><Reference><Citation>Kalafati L., Kourtzelis I. Innate Immune Training of Granulopoiesis Promotes Anti-Tumor Activity. Cell. 2020;183:771–785. doi: 10.1016/j.cell.2020.09.058.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.09.058</ArticleId><ArticleId IdType="pmc">PMC7599076</ArticleId><ArticleId IdType="pubmed">33125892</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang G.L., Huang H.L. Application of Hyaluronic Acid as Carriers in Drug Delivery. Drug Deliv. 2023;25:766–772. doi: 10.1080/10717544.2018.1450910.</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/10717544.2018.1450910</ArticleId><ArticleId IdType="pmc">PMC6058522</ArticleId><ArticleId IdType="pubmed">29536778</ArticleId></ArticleIdList></Reference><Reference><Citation>Pifferi C., Fuentes R., Fernández-Tejada A. Natural and synthetic carbohydrate-based vaccine adjuvants and their mechanisms of action. Nat. Rev. Chem. 2021;5:197–216. doi: 10.1038/s41570-020-00244-3.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41570-020-00244-3</ArticleId><ArticleId IdType="pmc">PMC7829660</ArticleId><ArticleId IdType="pubmed">33521324</ArticleId></ArticleIdList></Reference><Reference><Citation>Moni S.S., Abdelwahab S.I., Jabeen A., Elmobark M.E., Aqaili D., Ghoal G., Oraibi B., Farasani A.M., Jerah A.A., Alnajai M.M.A., et al. Advancements in Vaccine Adjuvants: The Journey from Alum to Nano Formulations. Vaccines. 2023;11:1704. doi: 10.3390/vaccines11111704.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines11111704</ArticleId><ArticleId IdType="pmc">PMC10674458</ArticleId><ArticleId IdType="pubmed">38006036</ArticleId></ArticleIdList></Reference><Reference><Citation>Savelkoul H.F., Ferro V.A., Strioga M.M., Schijns V.E. Choice and Design of Adjuvants for Parenteral and Mucosal Vaccines. Vaccines. 2015;3:148–171. doi: 10.3390/vaccines3010148.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines3010148</ArticleId><ArticleId IdType="pmc">PMC4494243</ArticleId><ArticleId IdType="pubmed">26344951</ArticleId></ArticleIdList></Reference><Reference><Citation>Filipić B., Pantelić I., Nikolić I., Majhen D., Stojić-Vukanić Z., Savić S., Krajišnik D. Nanoparticle-Based Adjuvants and Delivery Systems for Modern Vaccines. Vaccines. 2023;11:1172. doi: 10.3390/vaccines11071172.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/vaccines11071172</ArticleId><ArticleId IdType="pmc">PMC10385383</ArticleId><ArticleId IdType="pubmed">37514991</ArticleId></ArticleIdList></Reference><Reference><Citation>Colaço M., Costa J.P., Borges O. Glucan Particles: Choosing the Appropriate Size to Use as a Vaccine Adjuvant. Methods Mol. Biol. 2022;24:269–280.</Citation><ArticleIdList><ArticleId IdType="pubmed">34918250</ArticleId></ArticleIdList></Reference><Reference><Citation>Bowerman C.J., Nilsson B.L. A Reductive Trigger for Peptide Self-Assembly and Hydrogelation. J. Am. Chem. Soc. 2010;132:9526–9527. doi: 10.1021/ja1025535.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/ja1025535</ArticleId><ArticleId IdType="pubmed">20405940</ArticleId></ArticleIdList></Reference><Reference><Citation>Silvestre F., Santos C., Silva V., Ombredane A., Pinheiro W., Andrade L., Garcia M., Pacheco T., Joanitti G., Luz G., et al. Pharmacokinetics of Curcumin Delivered by Nanoparticles and the Relationship with Antitumor Efficacy: A Systematic Review. Pharmaceuticals. 2023;16:943. doi: 10.3390/ph16070943.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/ph16070943</ArticleId><ArticleId IdType="pmc">PMC10384157</ArticleId><ArticleId IdType="pubmed">37513855</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie M., Shimogawa R., Liu Y., Zhang L., Foucher A.C., Routh P.K., Stach E.A., Frenkel A.I., Knecht M.R. Biomimetic Control over Bimetallic Nanoparticle Structure and Activity via Peptide Capping Ligand Sequence. ACS Nano. 2024;18:3286–3294. doi: 10.1021/acsnano.3c10016.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsnano.3c10016</ArticleId><ArticleId IdType="pubmed">38227802</ArticleId></ArticleIdList></Reference><Reference><Citation>Cai L., Qin X., Xu Z., Song Y., Jiang H., Wu Y., Ruan H., Chen J. Comparison of Cytotoxicity Evaluation of Anticancer Drugs between Real-Time Cell Analysis and CCK-8 Method. ACS Omega. 2019;4:12036–12042. doi: 10.1021/acsomega.9b01142.</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acsomega.9b01142</ArticleId><ArticleId IdType="pmc">PMC6682106</ArticleId><ArticleId IdType="pubmed">31460316</ArticleId></ArticleIdList></Reference><Reference><Citation>Cui Y., Sun W., Li Q., Wang K., Wang Y., Lv F., Chen X., Peng X., Wang Y., Li J., et al. Effects of Caulis Spatholobi Polysaccharide on Immunity, Intestinal Mucosal Barrier Function, and Intestinal Microbiota in Cyclophosphamide-Induced Immunosuppressive Chickens. Front. Vet. Sci. 2022;9:833–842. doi: 10.3389/fvets.2022.833842.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fvets.2022.833842</ArticleId><ArticleId IdType="pmc">PMC8972122</ArticleId><ArticleId IdType="pubmed">35372558</ArticleId></ArticleIdList></Reference><Reference><Citation>Andoh K., Suenaga K., Sakaguchi M., Yamazaki K., Honda T. Decreased Neutralizing Antigenicity in IBV S1 Protein Expressed from Mammalian Cells. Virus Res. 2015;208:164–170. doi: 10.1016/j.virusres.2015.06.019.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.virusres.2015.06.019</ArticleId><ArticleId IdType="pmc">PMC7114517</ArticleId><ArticleId IdType="pubmed">26113306</ArticleId></ArticleIdList></Reference><Reference><Citation>Patil K.V., Canlon B., Cederroth C.R. High-Quality RNA Extraction of the Mammalian Cochlea for qRT-PCR and Transcriptome Analyses. Hear. Res. 2015;325:42–48. doi: 10.1016/j.heares.2015.03.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.heares.2015.03.008</ArticleId><ArticleId IdType="pubmed">25818515</ArticleId></ArticleIdList></Reference><Reference><Citation>Chumbe A., Izquierdo-Lara R., Calderón K., Fernández-Díaz M., Vakharia V.N. Development of a Novel Newcastle Disease Virus (NDV) Neutralization Test Based on Recombinant NDV Expressing Enhanced Green Fluorescent Protein. Virol. J. 2017;14:232. doi: 10.1186/s12985-017-0900-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12985-017-0900-8</ArticleId><ArticleId IdType="pmc">PMC5701357</ArticleId><ArticleId IdType="pubmed">29169354</ArticleId></ArticleIdList></Reference><Reference><Citation>Kopecek J., Yang J.Y. Peptide-Directed Self-Assembly of Hydrogels. Acta Biomater. 2009;5:805–816. doi: 10.1016/j.actbio.2008.10.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.actbio.2008.10.001</ArticleId><ArticleId IdType="pmc">PMC2677391</ArticleId><ArticleId IdType="pubmed">18952513</ArticleId></ArticleIdList></Reference><Reference><Citation>Radu L.C., Yang J., Kopeček J. Self-Assembling Diblock Copolymers of Poly[N-(2-Hydroxypropyl)Methac yramide] and a β-Sheet Peptide. Macromol. Biosci. 2009;9:36–44. doi: 10.1002/mabi.200800193.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/mabi.200800193</ArticleId><ArticleId IdType="pmc">PMC4599367</ArticleId><ArticleId IdType="pubmed">18855948</ArticleId></ArticleIdList></Reference><Reference><Citation>Foged C., Brodin B., Frokjaer S., Sundblad A. Particle Size and Surface Charge Affect Particle Uptake by Human Dendritic Cells in an In Vitro Model. Int. J. Pharm. 2005;298:315–322. doi: 10.1016/j.ijpharm.2005.03.035.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ijpharm.2005.03.035</ArticleId><ArticleId IdType="pubmed">15961266</ArticleId></ArticleIdList></Reference><Reference><Citation>Coffman R.L., Sher A., Seder R.A. Vaccine Adjuvants: Putting Innate Immunity to Work. Nature. 2010;468:933–943. doi: 10.1016/j.immuni.2010.10.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.immuni.2010.10.002</ArticleId><ArticleId IdType="pmc">PMC3420356</ArticleId><ArticleId IdType="pubmed">21029960</ArticleId></ArticleIdList></Reference><Reference><Citation>Menon A.P., Moreno B., Meraviglia-Crivelli D., Nonatelli F., Villanueva H., Barainka M., Zheleva A., van Santen H.M., Pastor F. Modulating T Cell Responses by Targeting CD3. Cancers. 2023;15:1189. doi: 10.3390/cancers15041189.</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cancers15041189</ArticleId><ArticleId IdType="pmc">PMC9953819</ArticleId><ArticleId IdType="pubmed">36831533</ArticleId></ArticleIdList></Reference><Reference><Citation>Ngoenkam J., Schamel W.W., Pongcharoen S. Selected Signalling Proteins Recruited to the T-Cell Receptor-CD3 Complex. Immunology. 2018;153:42–50. doi: 10.1111/imm.12809.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/imm.12809</ArticleId><ArticleId IdType="pmc">PMC5721247</ArticleId><ArticleId IdType="pubmed">28771705</ArticleId></ArticleIdList></Reference><Reference><Citation>Steier Z., Kim E.J.Y., Aylard D.A., Robey E.A. The CD4 Versus CD8 T Cell Fate Decision: A Multiomics-Informed Perspective. Annu. Rev. Immunol. 2024;42:235–258. doi: 10.1146/annurev-immunol-083122-040929.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev-immunol-083122-040929</ArticleId><ArticleId IdType="pubmed">38271641</ArticleId></ArticleIdList></Reference><Reference><Citation>Künzli M., Masopust D. CD4(+) T Cell Memory. Nat. Immunol. 2023;24:903–914. doi: 10.1038/s41590-023-01510-4.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-023-01510-4</ArticleId><ArticleId IdType="pmc">PMC10343737</ArticleId><ArticleId IdType="pubmed">37156885</ArticleId></ArticleIdList></Reference><Reference><Citation>Kennedy A., Waters E., Rowshanravan B., Hinze C., Williams C., Janman D., Fox T.A., Booth C., Pesenacker A.M., Halliday N., et al. Differences in CD80 and CD86 Transendocytosis Reveal CD86 as a Key Target for CTLA-4 Immune Regulation. Nat. Immunol. 2022;23:1365–1378. doi: 10.1038/s41590-022-01289-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41590-022-01289-w</ArticleId><ArticleId IdType="pmc">PMC9477731</ArticleId><ArticleId IdType="pubmed">35999394</ArticleId></ArticleIdList></Reference><Reference><Citation>Trzupek D., Dunstan M., Cutler A.J., Lee M., Godfrey L., Jarvis L., Rainbow D.B., Aschenbrenner D., Jones J.L., Uhlig H.H., et al. Discovery of CD80 and CD86 as Recent Activation Markers on Regulatory T Cells by Protein-RNA Single-Cell Analysis. Genome Med. 2020;12:55. doi: 10.1186/s13073-020-00756-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13073-020-00756-z</ArticleId><ArticleId IdType="pmc">PMC7315544</ArticleId><ArticleId IdType="pubmed">32580776</ArticleId></ArticleIdList></Reference><Reference><Citation>La Gruta N.L., Gras S., Daley S.R., Thomas P.G., Rossjohn J. Understanding the Drivers of MHC Restriction of T Cell Receptors. Nat. Rev. Immunol. 2018;18:467–478. doi: 10.1038/s41577-018-0007-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-018-0007-5</ArticleId><ArticleId IdType="pubmed">29636542</ArticleId></ArticleIdList></Reference><Reference><Citation>Corse E., Gottschalk R.A., Allison J.P. Strength of TCR-Peptide/MHC Interactions and In Vivo T Cell Responses. J. Immunol. 2011;186:5039–5045. doi: 10.4049/jimmunol.1003650.</Citation><ArticleIdList><ArticleId IdType="doi">10.4049/jimmunol.1003650</ArticleId><ArticleId IdType="pubmed">21505216</ArticleId></ArticleIdList></Reference><Reference><Citation>Gitlin A.D., Nussenzweig M.C. Immunology: Fifty Years of B Lymphocytes. Nature. 2015;517:139–141. doi: 10.1038/517139a.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/517139a</ArticleId><ArticleId IdType="pubmed">25567266</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang S.S., Yang H.X., He J., Yan B.C., Feng T., Liu J.K. Steccherins A-D, Chamigrane-Type Sesquiterpenes from the Fungus Steccherinum Ochraceum with Selective Inhibition on B Lymphocyte Proliferation. Phytochemistry. 2023;10:214. doi: 10.1016/j.phytochem.2023.113830.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.phytochem.2023.113830</ArticleId><ArticleId IdType="pubmed">37598992</ArticleId></ArticleIdList></Reference><Reference><Citation>Lopes P.D., Okino C.H., Fernando F.S. Inactivated Infectious Bronchitis Virus Vaccine Encapsulated in Chitosan Nanoparticles Induces Mucosal Immune Responses and Effective Protection against Challenge. Vaccine. 2018;36:2630–2636. doi: 10.1016/j.vaccine.2018.03.065.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.vaccine.2018.03.065</ArticleId><ArticleId IdType="pubmed">29653848</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao K., Sun Y.W., Chen G. Biological Evaluation of N-2-Hydroxypropyl Trimethyl Ammonium Chloride Chitosan as a Carrier for the Delivery of Live Newcastle Disease Vaccine. Carbohydr. Polym. 2016;149:28–39. doi: 10.1016/j.carbpol.2016.04.085.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.carbpol.2016.04.085</ArticleId><ArticleId IdType="pubmed">27261727</ArticleId></ArticleIdList></Reference><Reference><Citation>Cerutti A. The Regulation of IgA Class Switching. Nat. Rev. Immunol. 2008;8:421–434. doi: 10.1038/nri2322.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nri2322</ArticleId><ArticleId IdType="pmc">PMC3062538</ArticleId><ArticleId IdType="pubmed">18483500</ArticleId></ArticleIdList></Reference><Reference><Citation>De Salvo C., Buela K.A., Pizarro T.T. Cytokine-Mediated Regulation of Innate Lymphoid Cell Plasticity in Gut Mucosal Immunity. Front. Immunol. 2020;11:585319. doi: 10.3389/fimmu.2020.585319.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.585319</ArticleId><ArticleId IdType="pmc">PMC7794016</ArticleId><ArticleId IdType="pubmed">33424837</ArticleId></ArticleIdList></Reference><Reference><Citation>Kubo M. The Role of IL-4 Derived from Follicular Helper T (TFH) Cells and Type 2 Helper T (TH2) Cells. Int. Immunol. 2021;33:717–722. doi: 10.1093/intimm/dxab080.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/intimm/dxab080</ArticleId><ArticleId IdType="pubmed">34628505</ArticleId></ArticleIdList></Reference><Reference><Citation>Wynn T.A. IL-13 Effector Functions. Annu. Rev. Immunol. 2003;21:425–456. doi: 10.1146/annurev.immunol.21.120601.141142.</Citation><ArticleIdList><ArticleId IdType="doi">10.1146/annurev.immunol.21.120601.141142</ArticleId><ArticleId IdType="pubmed">12615888</ArticleId></ArticleIdList></Reference><Reference><Citation>Burke J.D., Young H.A. IFN-γ: A Cytokine at the Right Time, Is in the Right Place. Semin. Immunol. 2019;43:101–280. doi: 10.1016/j.smim.2019.05.002.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.smim.2019.05.002</ArticleId><ArticleId IdType="pmc">PMC7367502</ArticleId><ArticleId IdType="pubmed">31221552</ArticleId></ArticleIdList></Reference><Reference><Citation>Han J., Wu M., Liu Z. Dysregulation in IFN-γ Signaling and Response: The Barricade to Tumor Immunotherapy. Front. Immunol. 2023;14:1190333. doi: 10.3389/fimmu.2023.1190333.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2023.1190333</ArticleId><ArticleId IdType="pmc">PMC10233742</ArticleId><ArticleId IdType="pubmed">37275859</ArticleId></ArticleIdList></Reference><Reference><Citation>Levitz S.M., Golenbock D.T. Beyond empiricism: Informing vaccine development through innate immunity research. Cell. 2012;148:1284–1292. doi: 10.1016/j.cell.2012.02.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2012.02.012</ArticleId><ArticleId IdType="pmc">PMC3308125</ArticleId><ArticleId IdType="pubmed">22424235</ArticleId></ArticleIdList></Reference><Reference><Citation>Tam E.H., Peng Y., Cheah M.X.Y., Yan C., Xiao T. Neutralizing Antibodies to Block Viral Entry and for Identification of Entry Inhibitors. Antivir. Res. 2024;224:105834. doi: 10.1016/j.antiviral.2024.105834.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.antiviral.2024.105834</ArticleId><ArticleId IdType="pubmed">38369246</ArticleId></ArticleIdList></Reference><Reference><Citation>Abela I.A., Kadelka C., Trkola A. Correlates of Broadly Neutralizing Antibody Development. Curr. Opin. HIV AIDS. 2019;14:279–285. doi: 10.1097/COH.0000000000000552.</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/COH.0000000000000552</ArticleId><ArticleId IdType="pubmed">31107283</ArticleId></ArticleIdList></Reference><Reference><Citation>Ossendorp F., Ho N.I., Van Montfoort N. How B Cells Drive T-Cell Responses: A Key Role for Cross-Presentation of Antibody-Targeted Antigens. Adv. Immunol. 2023;160:37–57.</Citation><ArticleIdList><ArticleId IdType="pubmed">38042585</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle>